Ann: Investor Webinar Presentation, page-13

All teeing up nice Glitt...

"I would like to compare to another company that deals in small molicules, they they signed a deal for $702m this year and have very similair profiles to ourselves, now im not suggesting we will do a $702m deal pre clinic but it does bode well for smaller molicules to be doing deals pre clinic with big pharma"

The BoD in place is all here to push our IP's through the clinic but they are their imho mostly to extract as much value pre clinic as opposed to post clinic....

Wall has gone and a steady increase to hopefully that elusive $1b deal some on here have been elluding too for some time, that time is coming quicker and quicker as no BIG PHARMA would want to let this go to clinic on its own because when it works they would have to pay 10-20-30 times more than collaberating now...

TICK TOCK